CVS(CVS)
CVS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $408.50B | $425.96B | $449.27B | $478.19B | $498.69B |
| Low | $404.90B | $416.45B | $448.65B | $470.02B | $490.18B |
| High | $414.34B | $439.86B | $449.89B | $494.15B | $515.34B |
| EBITDA Avg | $17.19B | $17.92B | $18.90B | $20.12B | $20.98B |
| Low | $17.04B | $17.52B | $18.88B | $19.78B | $20.62B |
| High | $17.43B | $18.51B | $18.93B | $20.79B | $21.68B |
| EBIT Avg | $11.92B | $12.43B | $13.11B | $13.96B | $14.55B |
| Low | $11.82B | $12.15B | $13.09B | $13.72B | $14.31B |
| High | $12.09B | $12.84B | $13.13B | $14.42B | $15.04B |
| Net Income Avg | $9.51B | $10.66B | $12.18B | $13.90B | $15.50B |
| Low | $9.32B | $10.45B | $11.48B | $13.59B | $15.16B |
| High | $9.70B | $10.87B | $12.87B | $14.50B | $16.17B |
| EPS Avg | $7.42 | $8.39 | $9.65 | $10.93 | $12.20 |
| Low | $7.33 | $8.22 | $9.03 | $10.69 | $11.93 |
| High | $7.63 | $8.55 | $10.13 | $11.41 | $12.73 |
| Analysts (Rev / EPS) | 18 / 16 | 18 / 17 | 15 / 11 | 11 / 4 | 7 / 4 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $100.17B | $103.21B | $105.84B | $103.54B | $103.96B | $107.33B | $110.29B | $109.79B |
| Low | $97.40B | $101.38B | $103.58B | $101.33B | $101.74B | $105.04B | $107.94B | $107.45B |
| High | $101.53B | $105.65B | $110.10B | $107.72B | $108.15B | $111.65B | $114.74B | $114.22B |
| EBITDA Avg | $4.21B | $4.34B | $4.45B | $4.36B | $4.37B | $4.52B | $4.64B | $4.62B |
| Low | $4.10B | $4.27B | $4.36B | $4.26B | $4.28B | $4.42B | $4.54B | $4.52B |
| High | $4.27B | $4.45B | $4.63B | $4.53B | $4.55B | $4.70B | $4.83B | $4.81B |
| EBIT Avg | $2.92B | $3.01B | $3.09B | $3.02B | $3.03B | $3.13B | $3.22B | $3.20B |
| Low | $2.84B | $2.96B | $3.02B | $2.96B | $2.97B | $3.07B | $3.15B | $3.14B |
| High | $2.96B | $3.08B | $3.21B | $3.14B | $3.16B | $3.26B | $3.35B | $3.33B |
| Net Income Avg | $2.34B | $2.21B | $1.69B | $3.54B | $2.69B | $2.53B | $1.99B | $4.07B |
| Low | $2.26B | $2.09B | $1.64B | $3.44B | $2.61B | $2.46B | $1.94B | $3.95B |
| High | $2.44B | $2.27B | $1.78B | $3.72B | $2.83B | $2.67B | $2.10B | $4.28B |
| EPS Avg | $1.83 | $1.72 | $1.32 | $2.76 | $2.10 | $1.98 | $1.56 | $3.18 |
| Low | $1.76 | $1.63 | $1.28 | $2.69 | $2.04 | $1.93 | $1.52 | $3.09 |
| High | $1.91 | $1.77 | $1.39 | $2.91 | $2.21 | $2.08 | $1.64 | $3.35 |
| Analysts (Rev / EPS) | 11 / 14 | 11 / 14 | 5 / 10 | 5 / 10 | 6 / 6 | 9 / 7 | 5 / 6 | 4 / 7 |